Recital 4, Regulation (EU) 2025/2027

In forcesince 9 Oct 2025

Commission Implementing Regulation (EU) 2025/787 [Commission Implementing Regulation (EU) 2025/787 of 24 April 2025 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1,4-dimethylnaphthalene, amidosulfuron, bentazone, bixafen, clomazone, fenoxaprop-P, fludioxonil, fluoxastrobin, flutolanil, fluxapyroxad, gibberellic acid, gibberellins, halauxifen-methyl, mecoprop-P, paraffin oil, penthiopyrad, pirimiphos-methyl, propamocarb, propyzamide, prothioconazole, rimsulfuron, sedaxane and sulfoxaflor (OJ L, 2025/787, 25.4.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/787/oj).] extended the approval period of the active substance penthiopyrad until 31 October 2027, pending the remaining steps in the procedure for renewal of the approval of that active substance.